Sildenafil -- better known as Viagra -- is used to treat erectile dysfunction (ED). This substance prevents degradation of cyclic guanosine mono-phosphate (cGMP), which then ensures blood supply for an erection.
"We have been researching the effect of cGMP on fat cells for quite some time now. This is why sildenafil was a potentially interesting candidate for us," says Alexander Pfeifer, professor of pharmacology and toxicology at the University of Bonn, who led the study.
However, another effect of Viagra has been noticed quite some time ago. Mice given sildenafil over longer periods of time were resistant to obesity when fed with high-fat diet, the Journal of the Federation of American Societies for Experimental Biology reports.
Together with the PharmaCenter of the University of Bonn, the German Federal Institute for Drugs and Medical Devices (BfArM), and the Max Planck Institute for Heart and Lung Research, the team of Pfeifer studied the effect of sildenafil on fat cells in mice, according to a Bonn statement.
Researchers administered the ED drug to the rodents for seven days. "The effects were quite amazing," says Ana Kilic, Pfeifer's colleague. Sildenafil increased the conversion of white fat cells, which are found in human "problem areas", into beige ones in the animals.
"Beige fat cells burn the energy from ingested food and convert it to heat," says Pfeifer. Because the beige fat cells can "melt the fat" and thus fight obesity, researchers are very hopeful for their potential.
If white fat cells are further "stuffed" or accumulate lipids, they increase in size and can synthesize and release hormones which in turn cause inflammation. Thus increasing the risk for chronic diseases.
Such inflammatory responses may then lead to cardio-vascular diseases resulting in heart attacks and strokes, as well as cancer and diabetes. "It seems that sildenafil prevented the fat cells in these mice from getting onto that slippery slope," Pfeifer says.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
